Clinical trials
Phase 2 Carcinoma, Squamous Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
104 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 7 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Terminated | 21 |
| Recruiting | 19 |
| Active, not recruiting | 15 |
| Withdrawn | 7 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 9 |
| UNC Lineberger Comprehensive Cancer Center | 8 |
| University of Chicago | 5 |
| Dana-Farber Cancer Institute | 4 |
| Massachusetts General Hospital | 4 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| National Cancer Institute (NCI) | 3 |
| Dan Zandberg | 2 |
| Diwakar Davar | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Squamous Cell | 104 |
| Head and Neck Neoplasms | 39 |
| Squamous Cell Carcinoma of Head and Neck | 36 |
| Carcinoma, Non-Small-Cell Lung | 12 |
| Adenocarcinoma | 10 |
| Oropharyngeal Neoplasms | 10 |
| Skin Neoplasms | 9 |
| Lung Neoplasms | 8 |
| Mouth Neoplasms | 8 |
| Recurrence | 7 |
Trials
Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.
4 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.